Psoriasis August 22, 2025 By Rebecca Dotterweich A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis More Details Filed Under: More from Department of Dermatology Dermatopathology Fellowship Protected: Toronto GEM Meeting: Jul 27–29, 2009 Residency Training Program